NCT06987630

Brief Summary

The purpose of this clinical trial is to integrated pulmonary index to see if there is an effect on the incidence of hypoxemia during painless colonoscopy in older patients. Does composite pulmonary index monitoring reduce the incidence of hypoxemia? Is there a relationship between the value of the integrated pulmonary index and the patient's pulse oximetry? Continuous monitoring of the integrated pulmonary index in the experimental group was compared with the control group (no detection of the composite lung index) to see if continuous monitoring of the composite pulmonary index could reduce the incidence of hypoxemia in elderly patients. Participants will: Oxygen is provided through the nasal cannula, and respiratory parameters (end-tidal carbon dioxide partial pressure (PetCO2), pulse rate \[PR\], oxygen saturation (SpO2), and respiratory rate (RR) are obtained. The monitor calculates a integrated pulmonary index value (1-10) through mathematical operations.Different measures are taken according to different composite lung indexes, such as when the IPI is ≤6, the patient's jaw is immediately lifted, the oxygen flow rate increases to 6L·min-1, and if the SpO2 continues to decrease by \<90%, the anesthesia mask is pressurized and ventilated. Record their vital signs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
153

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 5, 2025

Completed
18 days until next milestone

First Posted

Study publicly available on registry

May 23, 2025

Completed
9 days until next milestone

Study Start

First participant enrolled

June 1, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2025

Completed
Last Updated

December 1, 2025

Status Verified

November 1, 2025

Enrollment Period

4 months

First QC Date

May 5, 2025

Last Update Submit

November 23, 2025

Conditions

Keywords

Elderly patientsColonoscopyPropofol

Outcome Measures

Primary Outcomes (1)

  • Incidence of hypotension

    the number of patients experiencing low blood pressure

    Perioperative

Secondary Outcomes (1)

  • Adverse reactions (dizziness, nausea, vomiting, etc.)

    Perioperative

Study Arms (2)

P group

EXPERIMENTAL

Nasal cannula oxygen inhalation, oxygen flow rate 3-4L/min, monitor the integrated pulmonary index and SpO2.

Device: monitor integrated pulmonary index(IPI) and take appropriate measures

C group

NO INTERVENTION

Nasal cannula oxygen inhalation, oxygen flow rate 3-4L/min,monitor the SpO2,

Interventions

When the IPI is ≤ 6, the patient's jaw is immediately lifted, the oxygen flow rate increases to 6L·min-1, and if the SpO2 continues to decrease by \<90%, the anesthesia mask is pressurized and ventilated.

P group

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Patients who were selected for non-intubated painless colonoscopy;
  • Age≥ 65 years;
  • American Society of Anesthesiologists (ASA) grade I\~III;
  • Conscious, no cognitive dysfunction and other mental illnesses;
  • Voluntarily participate in this study and sign the informed consent form

You may not qualify if:

  • Patients with severe circulatory system diseases, respiratory diseases, and central nervous system diseases;
  • Patients with severe abnormal liver and kidney function;
  • Those who are allergic to any of the drugs used in the study;
  • Participated in other clinical studies within the last 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First People's Hospital of Lianyungang City

Lianyungang, Jiangsu, 222000, China

Location

MeSH Terms

Conditions

Hypoxia

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 5, 2025

First Posted

May 23, 2025

Study Start

June 1, 2025

Primary Completion

October 1, 2025

Study Completion

October 31, 2025

Last Updated

December 1, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations